Fundz

Express Cells, Inc. reported raising $591,000 in an initial SEC Form D filing, from an offering of $650,000

PRIVATEApr 09, 2021$590.5K of $650K raised

Amount Raised

$591,000

$591,000 sold, per SEC Form D (first sale Apr 9, 2021)

Round Type

Seed

PhiladelphiaBiotechnology

Quick answer

ExpressCells, Inc. raised $591,000 in a Seed round, dated April 9, 2021. ExpressCells, Inc. is based in Philadelphia, Pennsylvania, United States.

How much did ExpressCells, Inc. raise?
ExpressCells, Inc. raised $591,000 in a Seed round on April 9, 2021.
What does ExpressCells, Inc. do?
ExpressCells create custom cell lines for biological research and drug discovery.
Where is ExpressCells, Inc. based and how big is it?
ExpressCells, Inc. is based in Philadelphia, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as ExpressCells, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • IMAGINE PHARMA LLC raised $350K on May 24, 2021.
  • Numab Therapeutics raised an undisclosed amount (Series C) on May 20, 2021.
  • Haya Therapeutics raised an undisclosed amount (Seed) on May 20, 2021.
  • Immunome Inc. raised an undisclosed amount (Grant) on May 20, 2021.
  • Allied BioScience, Inc. raised $250K on May 19, 2021.
  • MAIA Biotechnology raised $8M (Funding Round) on May 19, 2021.

Who to call at ExpressCells, Inc., and when

A new round usually means ExpressCells, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ExpressCells, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ExpressCells, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ExpressCells, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ExpressCells, Inc.

Location

3675 MARKET ST., SUITE 200

Philadelphia, Pennsylvania, United States

About

ExpressCells create custom cell lines for biological research and drug discovery.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ExpressCells, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for ExpressCells, Inc.'s next move

See what Strategic adds

ExpressCells, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.